Literature DB >> 9355898

Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure.

P Ponikowski1, T P Chua, M Piepoli, D Ondusova, K Webb-Peploe, D Harrington, S D Anker, M Volterrani, R Colombo, G Mazzuero, A Giordano, A J Coats.   

Abstract

BACKGROUND: The precise mechanisms responsible for the sympathetic overactivity and blunted baroreflex control in chronic heart failure (CHF) remain obscure. Augmented peripheral chemosensitivity has recently been demonstrated in CHF. We evaluated the relation between peripheral chemoreflex sensitivity and autonomic activity in patients with CHF. METHODS AND
RESULTS: We studied in 26 stable patients with CHF the peripheral chemosensitivity (ventilatory response to hypoxia using transient inhalations of pure nitrogen), autonomic balance (spectral analysis of heart rate variability [HRV]), and baroreflex sensitivity (bolus phenylephrine method and alpha index). To determine whether transient inactivation of peripheral chemoreceptors might influence autonomic balance, 12 patients underwent a second study during which they breathed 100% O2. Peripheral chemosensitivity correlated inversely with HRV power within the low-frequency band (0.04 to 0.15 Hz) (r=-.52, P=.006) and inversely with baroreflex sensitivity (r=-.60, P=.005). When the patients were divided into two groups according to the chemosensitivity of age-matched normal controls (above and below mean+2 SDs of chemosensitivity of control subjects), those above the normal range revealed more impaired autonomic balance, ie, lower baroreflex sensitivity (1.4 +/- 1.3 versus 5.0 +/- 1.5 ms/mm Hg, P<.0001) and depressed values of low-frequency power (2.5 +/- 1.8 versus 4.1 +/- 0.8 ln ms2, P<.005) compared with those with normal chemosensitivity. Transient hyperoxia did not alter heart rate or systolic pressure but resulted in an increase in HRV and an improvement in baroreflex sensitivity.
CONCLUSIONS: A link between increased peripheral chemosensitivity and impaired autonomic control, including baroreflex inhibition, is demonstrated. The clinical importance of this phenomenon warrants further investigation.

Entities:  

Mesh:

Year:  1997        PMID: 9355898     DOI: 10.1161/01.cir.96.8.2586

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  62 in total

1.  Effect of bilateral carotid body resection on cardiac baroreflex control of blood pressure during hypoglycemia.

Authors:  Jacqueline K Limberg; Jennifer L Taylor; Michael T Mozer; Simmi Dube; Ananda Basu; Rita Basu; Robert A Rizza; Timothy B Curry; Michael J Joyner; Erica A Wehrwein
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

2.  Central sleep apnea indicates autonomic dysfunction in asymptomatic carotid stenosis: a potential marker of cerebrovascular and cardiovascular risk.

Authors:  Sven Rupprecht; Dirk Hoyer; Georg Hagemann; Otto W Witte; Matthias Schwab
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 3.  Mechanisms by which exercise training benefits patients with heart failure.

Authors:  Ettore Crimi; Louis J Ignarro; Francesco Cacciatore; Claudio Napoli
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

4.  Interaction between central-peripheral chemoreflexes and cerebro-cardiovascular control.

Authors:  Lucia Spicuzza; Cesare Porta; Alfina Bramanti; Mara Maffeis; Gaia Casucci; Nadia Casiraghi; Luciano Bernardi
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

Review 5.  The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.

Authors:  John S Floras; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2015-05-13       Impact factor: 29.983

Review 6.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

Review 7.  Integrated Cardio-Respiratory Control: Insight in Diabetes.

Authors:  Luciano Bernardi; Lucio Bianchi
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

8.  Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure.

Authors:  Angela Beatrice Scardovi; Renata De Maria; Andrea Celestini; Claudio Coletta; Nadia Aspromonte; Silvia Perna; Marina Parolini; Roberto Ricci
Journal:  Intern Emerg Med       Date:  2008-06-17       Impact factor: 3.397

Review 9.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

10.  Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.

Authors:  Camilo Toledo; David C Andrade; Claudia Lucero; Alexis Arce-Alvarez; Hugo S Díaz; Valentín Aliaga; Harold D Schultz; Noah J Marcus; Mónica Manríquez; Marcelo Faúndez; Rodrigo Del Rio
Journal:  J Physiol       Date:  2017-03-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.